Barrett's esophagus overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 75: Line 75:


===Other Diagnostic Studies===
===Other Diagnostic Studies===
There are no other diagnostic studies associated with Barrett's esophagus.


==Treatment==
==Treatment==

Revision as of 16:30, 5 February 2018

Barrett's Esophagus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Barrett's Esophagus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Barrett's esophagus overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Barrett's esophagus overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Barrett's esophagus overview

CDC on Barrett's esophagus overview

Barrett's esophagus overview in the news

Blogs on Barrett's esophagus overview

Directions to Hospitals TreatingBarrett's esophagus

Risk calculators and risk factors for Barrett's esophagus overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amresh Kumar MD [2], Hamid Qazi, MD, BSc [3]

https://www.youtube.com/watch?v=m6FIrOAe2TY&t%7C350}}

Overview

Barrett's esophagus refers to an abnormal change (metaplasia) in the cells of the lower end of the esophagus thought to be caused by damage from chronic acid exposure, or reflux esophagitis.[1] It is a condition in which any extent of metaplastic columnar epithelium replaces the normal stratified squamous epithelium in the distal esophagus.

Intestinal metaplasia is required for the diagnosis of Barrett's esophagus.[2]

Historical Perspective

Barrett's esophagus was first discovered by Dr. Norman Barrett, a Australian-born British surgeon at St Thomas' Hospital, in 1957.

Classification

There is no established system for the classification of Barrett's esophagus.

Pathophysiology

Barrett's esophagus is marked by the presence of columnar epithelium in the lower esophagus, replacing the normal squamous cell epithelium; an example of metaplasia. The columnar epithelium is better able to withstand the erosive action of the gastric secretions; however, this metaplasia confers an increased cancer risk of the adenocarcinoma type.

Causes

Barrett's Oesophagus is commonly caused by Gastroesophageal reflux disease.

Differentiating ((Page name)) from Other Diseases

Barrett's Oesophagus must be differentiated from esophagitis, peptic ulcer disease, and esophageal motor disorders.

Epidemiology and Demographics

Barrett's esophagus can be seen in younger patients, but is most commonly diagnosed in patients ~ 55 years old. The prevalence of Barrett's esophagus is approximately 2000 per 100,000 individuals worldwide.

Risk Factors

The most potent risk factor in the development of Barret's Oesophagus is Chronic GERD. Other risk factors include Age (>older than 50 years), Sex (male), Race (caucasian), hiatal hernia, elevated body mass index and intra-abdominal distribution of body fat.

Screening

Barrett's esophagus is a major risk factor for development of esophageal adenocarcinoma. After diagnosis, regular surveillance is needed based on the grade of dysplasia. Weak recommendation, moderate-quality evidence: screening in patients with multiple risk factors for esophageal adenocarcinoma: Age > 50 years old, male, white, chronic GERD, hiatal hernia, elevated BMI (body mass index), and intra-abdominal distribution of body fat. Strong recommendation, low-quality evidence against screening general population with GERD and no risk factors.

Natural History, Complications, and Prognosis

Common complications of Barrett's esophagus include esophageal carcinoma, esophageal stricture and esophageal ulcers.

Diagnosis

Diagnostic Criteria

The diagnosis of Barrett's esophagus is made on endoscopy, when at least 2 of the following diagnostic criteria are met which include presence of columnar epithelium in the distal esophagus and the presence of intestinal metaplasia in the columnar epithelium lining the distal esophagus.

History and Symptoms

Common symptoms of Barrett's esophagus include heart burnregurgitation, and dysphagia. A positive history of nauseavomiting, and regurgitation is suggestive of Barrett's esophagus. Other symptoms of Barrett's esophagus include chest paincough, and odynophagia.

Physical Examination

Patients with Barrett's esophagus usually appear ill due to the pain. Common physical examination include hoarseness of voice, laryngitisotitis media, and lung wheezes.

Laboratory Findings

Laboratory findings consistent with diagnosis of Barrett's esophagus is the presence of acidic reflux in the esophagus through the ambulatory reflux monitoring.

Electrocardiogram

There are no EKG findings associated with Barrett's esophagus. However, EKG can be performed to exclude the cardiac causes of chest pain that can be presented in cases of atypical GERD.

X-ray

There are no x-ray findings associated with Barrett's esophagus.

Ultrasound

There are no echocardiography or ultrasound findings associated with Barrett's esophagus.

CT scan

There are no CT scan findings associated with Barrett's esophagus.

MRI

There are no MRI findings associated with Barrett's esophagus.

Other Imaging Findings

Unsedated esphagoscopy and capsule esophagoscopy may be helpful in the diagnosis of Barrett's esophagus.

Other Diagnostic Studies

There are no other diagnostic studies associated with Barrett's esophagus.

Treatment

Medical Therapy

Surgery

Primary Prevention

Effective measures for the primary prevention of Barrett's esophagus include lifestyle modifications and medical therapy for GERD. Lifestyle mmodificatin include weight loss, head of bed elevation, avoidance of nighttime meals, and elimination of trigger foods such as chocolate, caffeine and alcohol. Medical therapy include the use of proton pump inhibitors.

Secondary Prevention

Effective measures for the secondary prevention of Barrett's esophagus include primary prevention along with endoscopic surveillance every 3-5 years for no dysplasia, 6-12 months for low-grade dysplasia, and every 3 months for high-grade dysplasia in the absence of eradication therapy.

References

  1. Stein H, Siewert J (1993). "Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management". Dysphagia. 8 (3): 276–88. PMID 8359051.
  2. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ (2011). "American Gastroenterological Association medical position statement on the management of Barrett's esophagus". Gastroenterology. 140 (3): 1084–91. PMID 21376940. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources